Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»PD-L1 protein expression patterns in renal cell carcinoma based on conventional and digitized evaluation
    Volume 26, Issue 6

    PD-L1 protein expression patterns in renal cell carcinoma based on conventional and digitized evaluation

    November 30, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Paraskevi Tziakou1*, Grigorios Theodoropoulos2*, Evangelos Tsiambas3,4*, Gerasimos Kollaitis2, Eirini Thymara4, Nikolaos Kavantzas4, Andreas C. Lazaris4

    1Department of Pathology, “Thriasio” General Hospital of Elefsina, Elefsina, Greece.

    2Department of Urology, Athens General Hospital “Elpis”, Athens, Greece.

    3Department of Cytology, 417 VA (NIMTS), Athens, Greece.

    4Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

    *Authors equally contributed

    Summary

    Purpose: Programmed cell death ligand-1 (PD-L1), also known as CD274 (cytogenetic band: 9p24.1), is expressed predominantly in most hematopoietic cells and also in epithelial cells. Our aim was to evaluate PD-L1 protein expression in renal cell carcinoma (RCC) tissues by comparatively implementing conventional and also digitized assays.

    Methods: We used 100 archival, formalin-fixed and paraffin-embedded RCC tissue specimens, including 75 histologically confirmed clear cell RCC, 13 papillary RCCs, and 12 chromophobe RCC. Immunohistochemistry was performed implementing an anti- PD-L1 antibody. Conventional (Tumor Proportion Score (TPS)-qualitative) and also digital image analysis (DIA-quantitative) assays were applied for evaluating the corresponding protein expression levels.

    Results: According to DIA, negative or loss of PD-L1 expression was observed in 92 cases (92%), in 2 (2%) of them moderate levels were detected, whereas 6 (6%) were characterized by strong (high) expression. Based on the TPS evaluation, 8 (8%) cases were characterized as positive, whereas the rest of them (92/92%) as negative. Interestingly, kappa analysis revealed a high level of overall correlation between qualitative and quantitative based assays (kappa=0.94).

    Conclusions: PD-L1 overexpression is detected in low rates in RCC, especially in the clear cell carcinoma histological variety. Implementation of digitized (staining intensity) analytical methods provides an objective and accurate approach matching with the conventional protein expression evaluation and categorization as positive/negative cases.

    Key words: renal carcinoma, PD-L1, protein, image analysis, immunotherapy.

    Full Text: PDF

    Original Article
    Previous ArticleFirst-line pazopanib in metastatic renal cell carcinoma: Multicenter experience
    Next Article Significance of prostate health index and its density to predict aggressive prostate cancer at final pathology

    Related Articles

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.